alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.5



 Exhibit 10.5 

WARRANT EXCHANGE AGREEMENT 

in relation to warrants to subscribe for shares in Midatech Limited 

 

					
	1.	 	WARRANTHOLDER:	  	  

     
  

		 		  	
			 
	2.	 	ADDRESS:	  	      

 

			
		 		  	
	3.	 	NUMBER OF WARRANTS:	  	 
    
  

			
		 		  	 


 I/We the Warrantholder in Midatech Limited named above HEREBY agree to exchange with Midatech Pharma PLC
(“MPL”) all of our interest in those Warrants in my/our name set at above in consideration of the issue of that amount ordinary shares of £0.0001 each in MPL set out in box 4 below, (“Consideration Shares”).
I/We agree to deliver up to MPL the certificates for the Warrants described above and for such Warrants to be immediately cancelled. 
 I/We the
Warrantholder acknowledge and agree that upon the issue of the Consideration Shares and the cancellation of the Warrants all my/our interest in the Warrants shall cease and I/We shall no longer have a right to subscribe for ordinary shares in
Midatech Limited. 
  

					
		
	4.	 	 AMOUNT OF CONSIDERATION SHARES:
  

	 
	 


 MPL agrees with the Warrantholder named above to issue the Consideration Shares for those Warrants also described above.

  

					
	  
	 		 	  

	 Signed for and on
 behalf of
Warrantholder
	 		 	 Signed for and on
 behalf of Midatech Pharma
PLC

			
	Dated    28 November 2014	 		 	Dated    28 November 2014
I 

118TH CONGRESS 

1ST SESSION H. R. 2176 

To provide for a limitation on availability of funds for U.S. Department 

of Interior, Abandoned Mine Reclamation Fund for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Natural Resources 

A BILL 

To provide for a limitation on availability of funds for U.S. 

Department of Interior, Abandoned Mine Reclamation 

Fund for fiscal year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

4 U.S. DEPARTMENT OF INTERIOR, ABAN5 DONED MINE RECLAMATION FUND FOR FIS6 CAL YEAR 2024. 

7 Notwithstanding any other provision of the law, 

8 amounts authorized to be appropriated or otherwise avail9 able for U.S. Department of Interior, Abandoned Mine 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 2176 IH

1 Reclamation Fund for fiscal year 2024 may not exceed 

2 $24,672,000. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
Exhibit
      32.1




**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
      SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
      OF
      2002**





In
      connection with the Quarterly Report of Composite Technology Corporation (the
      “Company”) on Form 10-Q for the quarter ended June 30, 2008, as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      Benton H. Wilcoxon, Chief Executive Officer of the Company, certify, pursuant
      to
      18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
      2002, that, to the best of my knowledge:





(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934; and(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and result of operations of the
                Company.








/s/
                Benton H WilcoxonBenton
                H WilcoxonChief
                Executive Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1915 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 1915

  To provide for a limitation on availability of funds for Library of 
Congress, Books for the Blind and Physically Handicapped, Salaries and 
                     Expenses for fiscal year 2024.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 29, 2023

Mr. Biggs (for himself, Mr. Rosendale, Mr. Gaetz, Mr. Good of Virginia, 
   Mr. Roy, and Mr. Crane) introduced the following bill; which was 
           referred to the Committee on House Administration

_______________________________________________________________________

                                 A BILL

 
  To provide for a limitation on availability of funds for Library of 
Congress, Books for the Blind and Physically Handicapped, Salaries and 
                     Expenses for fiscal year 2024.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR LIBRARY OF CONGRESS, 
              BOOKS FOR THE BLIND AND PHYSICALLY HANDICAPPED, SALARIES 
              AND EXPENSES FOR FISCAL YEAR 2024.

    Notwithstanding any other provision of the law, amounts authorized 
to be appropriated or otherwise available for Library of Congress, 
Books for the Blind and Physically Handicapped, Salaries and Expenses 
for fiscal year 2024 may not exceed $52,783,000.
                                 <all>
```
Exhibit 10.8


NuGene International, Inc. (NUGN)


 







 


May 26, 2015


 


 





	Donna Queen 	



 








 


Dear Donna:


 


On behalf of NuGene International, Inc., I am pleased to invite
you to join the Board of Directors of NuGene International, Inc. Our Board and management firmly believes that the future promises
to be exciting for NuGene and we feel your experience and leadership in the skincare arena will be invaluable as we grow our company
and advance our groundbreaking collection of antiaging products.


 


The Board of Directors plays a central role in NuGene's success
and each Board Member is a business professional who delivers sound business direction, expertise, knowledge, and professional
relationships that advance the company's goals and objectives. Additionally, the Board participates in policy development, major
decision making and investor relations activities. The Board meets four times a year and on occasion, members of our Board represent
NuGene at key fundraising events. The terms of the members of our Company’s Board of Directors are prescribed by our Company’s
bylaws and subject to periodic nomination and election by the Company’s shareholders.


 


In connection with your service, you will be paid an annual
director stipend of $30,000. Additionally, you will be issued 100,000 shares of the Company’s common stock that will vest
at the rate of 25,000 shares on the third, sixth, ninth and twelve months’ anniversary dates of this agreement.


 


I am excited about NuGene's future and I look forward to the
solid leadership, fresh ideas and other contributions that you will bring to the company.


 


Very truly yours,


 


/s/ Ali Kharazi                            


Ali Kharazmi, CEO


NuGene International, Inc.


Dated: May 26, 2015


 


Accepted:


 


/s/ Donna Queen                          


Donna Queen


Dated: May 26, 2015


 


 




 


 


 





17912 Cowan, Suite A, Irvine,
California 92614


Phone: (714) 641-2640 |
Fax: (714) 641-2646
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements as of and for the nine months ended September 27, 1998 and
is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                                  0000317540
<NAME>                                 COCA-COLA BOTTLING CO. CONSOLIDATED
<MULTIPLIER>                           1,000
<CURRENCY>                             U.S. DOLLARS
       
<S>                                  <C>
<PERIOD-TYPE>                          9-MOS
<FISCAL-YEAR-END>                      JAN-03-1999
<PERIOD-START>                         DEC-29-1997
<PERIOD-END>                           SEP-27-1998
<EXCHANGE-RATE>                                  1
<CASH>                                       5,944
<SECURITIES>                                     0
<RECEIVABLES>                               61,368
<ALLOWANCES>                                   529
<INVENTORY>                                 44,207
<CURRENT-ASSETS>                           147,141
<PP&E>                                     446,741
<DEPRECIATION>                             189,258
<TOTAL-ASSETS>                             835,287
<CURRENT-LIABILITIES>                      133,336
<BONDS>                                    502,898
<COMMON>                                    12,055
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<OTHER-SE>                                   4,866
<TOTAL-LIABILITY-AND-EQUITY>               835,287
<SALES>                                    693,279
<TOTAL-REVENUES>                           693,279
<CGS>                                      398,515
<TOTAL-COSTS>                              398,515
<OTHER-EXPENSES>                           240,957
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                          29,069
<INCOME-PRETAX>                             21,774
<INCOME-TAX>                                 7,852
<INCOME-CONTINUING>                         13,922
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                13,922
<EPS-PRIMARY>                                 1.66
<EPS-DILUTED>                                 1.64
        

</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE   SCHEDULE   CONTAINS   SUMMARY   FINANCIAL   INFORMATION   EXTRACTED   FROM
CREDITRISKMONITOR.COM,  INC.'S JUNE 30, 1999, FORM 10-Q FINANCIAL STATEMENTS AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                             DEC-31-1999
<PERIOD-START>                                JAN-01-1999
<PERIOD-END>                                  JUN-30-1999
<CASH>                                        1,644
<SECURITIES>                                  0
<RECEIVABLES>                                 379
<ALLOWANCES>                                  0
<INVENTORY>                                   0
<CURRENT-ASSETS>                              2,036
<PP&E>                                        268
<DEPRECIATION>                                25
<TOTAL-ASSETS>                                4,526
<CURRENT-LIABILITIES>                         1,029
<BONDS>                                       0
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                      53
<OTHER-SE>                                    2,508
<TOTAL-LIABILITY-AND-EQUITY>                  4,526
<SALES>                                       561
<TOTAL-REVENUES>                              599
<CGS>                                         0
<TOTAL-COSTS>                                 1,087
<OTHER-EXPENSES>                              137
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                            38
<INCOME-PRETAX>                               (663)
<INCOME-TAX>                                  0
<INCOME-CONTINUING>                           (663)
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                                  (663)
<EPS-BASIC>                                   (0.13)
<EPS-DILUTED>                                 (0.13)



</TABLE>
**EXHIBIT 31.2**I, James Follo, certify that:1. I have reviewed this annual report on Form 10-K of Martha Stewart Living Omnimedia, Inc;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) andinternal control over financial reporting (as defined in Exchange Act Rules 13a — 15(f) and 15(d) -15(f)) for the registrant and have:a. Designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;b. Designed such internal control over financial reporting, or caused such internalcontrol over financial reporting to be designed under our supervision, to providereasonable assurance regarding the reliability of financial reporting and thepreparation of financial statements for external purposes in accordance with generallyaccepted accounting principles;c. Evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based onsuch evaluation; andd. Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s fourth fiscal quarter thathas materially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting 5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):a. All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; andb. Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.Date: March 7, 2006   /s/ James Follo   Chief Financial and Administrative Officer  
2
**Exhibit 18**

 

 

March 31, 2006

 

Audit Committee of the Board of DirectorsChemtura Corporation199 Benson RoadMiddlebury, CT 06749

 

Ladies and Gentlemen:

 

We have audited the consolidated balance sheets of Chemtura Corporation(the “Company”) as of December 31, 2005 and 2004, and the relatedconsolidated statements of operations, cash flows and stockholders’ equity foreach of the years in the three-year period ended December 31, 2005, andhave reported thereon under the date of March 31, 2006. The aforementionedconsolidated financial statements and our audit report thereon are included inthe Company’s annual report on Form 10-K for the year ended December 31,2005. As stated in the Accounting Policies and Pension and Post-retirementfootnotes to these financial statements, the Company changed the measurementdate for its pension and post-retirement health care plans from December 31to November 30 and states that the newly adopted accounting principle ispreferable in the circumstances because it provides management additional timeto review and reflect the actuarial information in the Company’s consolidatedfinancial statements under the Securities and Exchange Commission’s acceleratedfiling deadlines. In accordance with your request, we have reviewed and discussedwith Company management the circumstances and business judgment and planningupon which the decision to make this change in the method of accounting wasbased.

 

With regard to the aforementioned accounting change, authoritativecriteria have not been established for evaluating the preferability of oneacceptable method of accounting over another acceptable method. However, forpurposes of the Company’s compliance with the requirements of the Securitiesand Exchange Commission, we are furnishing this letter.

 

Based on our review and discussion, with reliance on management’sbusiness judgment and planning, we concur that the newly adopted method ofaccounting is preferable in the Company’s circumstances.

 

Very truly yours,

 

/s/ KPMG LLP

 

----
I 

118TH CONGRESS 

1ST SESSION H. R. 1965 

To provide for a limitation on availability of funds for Department of Health 

and Human Services, Centers for Disease Control and Prevention Birth 

Defects, Developmental Disabilities, Disabilities and Health for fiscal 

year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for 

Disease Control and Prevention Birth Defects, Developmental Disabilities, Disabilities and Health for fiscal year 

2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 1965 IH

1 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

2 DEPARTMENT OF HEALTH AND HUMAN SERV3 ICES, CENTERS FOR DISEASE CONTROL AND 

4 PREVENTION BIRTH DEFECTS, DEVELOP5 MENTAL DISABILITIES, DISABILITIES AND 

6 HEALTH FOR FISCAL YEAR 2024. 

7 Notwithstanding any other provision of the law, 

8 amounts authorized to be appropriated or otherwise avail9 able for Department of Health and Human Services, Cen10 ters for Disease Control and Prevention Birth Defects, 

11 Developmental Disabilities, Disabilities and Health for fis12 cal year 2024 may not exceed $155,560,000. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
**EXHIBIT 10.13**

 

ANDREW CORPORATION

EXECUTIVE SEVERANCE BENEFIT PLAN AGREEMENT

 

THIS AGREEMENT, made this 5th day of July, 2004, by and between AndrewCorporation (the “Company”) and John Dickson (the “Executive”),

 

WITNESSETH:

 

WHEREAS, the Company maintains the Andrew Corporation ExecutiveSeverance Benefit Plan, as amended and restated effective May 14, 2004 (the“Plan”); and

 

WHEREAS, the Executive has been designated as an eligible participantin the Plan;

 

NOW, THEREFORE, the Executive and Company hereby agree as follows:

 

1.                                       PlanBenefits.  The Executive has beendesignated as a TIER II Participant in the Plan and shall be eligible solelyfor the benefits set forth therein applicable to TIER II Participants.  The receipt of such benefits shall be subjectto all of the terms and conditions set forth in the Plan, including, but notlimited to, terms related to the amount, time and form of benefits.  By execution of this Agreement, theExecutive agrees to be bound by the provisions of the Plan, as amended andrestated effective May 14, 2004, and as may be subsequently amended.

 

2.                                       Arbitration.  The Executive acknowledges thatSection 7.2 of the Plan contains an arbitration provision, and byexecution of this Agreement agrees to be bound by the terms of such arbitrationprovision.

 

3.                                       PlanNot Contract of Employment.  ThePlan does not constitute a contract of employment and nothing in the Plan shallbe construed to give the Executive the right to be retained by the Company orto any benefits not specifically provided by the Plan.

 

4.                                       PlanSupercedes Prior Change in Control Severance Agreements.  The Executive acknowledges and agrees thatthe benefits and terms set forth in the May 14, 2004 restatement of the Plan,as applicable to the Participant based on the Tier designated in paragraph 1above, are a replacement for and in lieu of any benefits to which the Executivemay have been entitled under the Plan prior to its restatement or under anyother agreement with the Company relating to Change in Control severancebenefits.  The Executive furtheracknowledges such benefits and terms may be subsequently amended pursuant toSection 7.1 of the Plan.

 

IN WITNESS WHEREOF, the parties have caused this Agreement to beexecuted as of the date first above written.

 
| EXECUTIVE             | ANDREW CORPORATION                           |
|-----------------------|----------------------------------------------|
|                  |                                         |
|                  |                                         |
| /s/ John R.D. Dickson |                                         | /s/ Ralph E. Faison |   |
| , individually        |                                         | By: Ralph E. Faison |
|                  | Its: President & Chief Executive Officer |
|                       |                                              |  |  |  |

 

----